<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:department>Centre for Mechanisms of Human Toxicity</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles/><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0100874"><gtr:id>FD3F547F-55C4-4694-ABDE-2932DD47BB3C</gtr:id><gtr:title>Preclinical studies of cancer chemopreventive agents</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0100874</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1161439</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cancer Prevention</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>38A3D0DF-0ECD-4018-837F-2C0693F66F7F</gtr:id><gtr:impact>Many questions at talks

Invitation to give further lectures</gtr:impact><gtr:outcomeId>D1orDDJoJsH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Programme Grant</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>F8CA655A-4D6A-42B7-9FC4-6BA87E351C42</gtr:id><gtr:outcomeId>042E403792B0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>colorectal cancer chemoprevention</gtr:description><gtr:id>54CC37EF-95AE-4210-A56A-0E26DD030156</gtr:id><gtr:impact>dont know yet</gtr:impact><gtr:outcomeId>CF57561707A</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>pentamethoxyflavone</gtr:title><gtr:type>Preventative Intervention - Nutrition and Chemoprevention</gtr:type><gtr:yearDevCompleted>2006</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BB76573C-0018-483B-A551-36F3D3009976</gtr:id><gtr:title>Breast cancer prevention by green tea catechins and black tea theaflavins in the C3(1) SV40 T,t antigen transgenic mouse model is accompanied by increased apoptosis and a decrease in oxidative DNA adducts.</gtr:title><gtr:parentPublicationTitle>Journal of agricultural and food chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a53e5c880b1c6ad2c305e198d2444be"><gtr:id>1a53e5c880b1c6ad2c305e198d2444be</gtr:id><gtr:otherNames>Kaur S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-8561</gtr:issn><gtr:outcomeId>7FA58227854</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6207F306-EBF8-46D0-AA69-81E80A97871E</gtr:id><gtr:title>Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine.</gtr:title><gtr:parentPublicationTitle>Cancer chemotherapy and pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee25f45cc85857bf9569d83c4b827c4f"><gtr:id>ee25f45cc85857bf9569d83c4b827c4f</gtr:id><gtr:otherNames>Marczylo TH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0344-5704</gtr:issn><gtr:outcomeId>26FD048AF44</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>734E7CCB-49E8-457D-8C22-50DE69A05E6F</gtr:id><gtr:title>Do anthocyanins and anthocyanidins, cancer chemopreventive pigments in the diet, merit development as potential drugs?</gtr:title><gtr:parentPublicationTitle>Cancer chemotherapy and pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40bbfa4247b75d7cf5b48f845715b4e0"><gtr:id>40bbfa4247b75d7cf5b48f845715b4e0</gtr:id><gtr:otherNames>Thomasset S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0344-5704</gtr:issn><gtr:outcomeId>pm_15429_19_19294386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5436FF57-8F60-4FAF-9CE6-9FDB67B5D2F3</gtr:id><gtr:title>Effects of the potential chemopreventive agent DMU-135 on adenoma development in the ApcMin+ mouse</gtr:title><gtr:parentPublicationTitle>Investigational New Drugs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79601c276cd9e784c40ff2c0b6413954"><gtr:id>79601c276cd9e784c40ff2c0b6413954</gtr:id><gtr:otherNames>Sale S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0167-6997</gtr:issn><gtr:outcomeId>1D5FF38174F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>636C565A-9725-4FC8-8DEA-C483363A8427</gtr:id><gtr:title>Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79601c276cd9e784c40ff2c0b6413954"><gtr:id>79601c276cd9e784c40ff2c0b6413954</gtr:id><gtr:otherNames>Sale S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>6EE8BEAA785</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32E2B54C-B20F-4D5A-923F-05870F5DDCF9</gtr:id><gtr:title>Flavones as colorectal cancer chemopreventive agents--phenol-o-methylation enhances efficacy.</gtr:title><gtr:parentPublicationTitle>Cancer prevention research (Philadelphia, Pa.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4d099021b017a4a40fe01dcb55d9ec0"><gtr:id>b4d099021b017a4a40fe01dcb55d9ec0</gtr:id><gtr:otherNames>Cai H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1940-6215</gtr:issn><gtr:outcomeId>pm_15429_19_19638489</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B482B057-5FD3-4A9C-A6F6-8E1E2D58EDA7</gtr:id><gtr:title>Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.</gtr:title><gtr:parentPublicationTitle>The Prostate</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/478c4c020c27a188fdecfa06eb531727"><gtr:id>478c4c020c27a188fdecfa06eb531727</gtr:id><gtr:otherNames>Teichert F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-4137</gtr:issn><gtr:outcomeId>CE73078D33A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB4788C0-E7F5-4767-84EB-D178F7F98B1C</gtr:id><gtr:title>Determination of 3',4',5',5,7-pentamethoxyflavone in the plasma and intestinal mucosa of mice by HPLC with UV detection.</gtr:title><gtr:parentPublicationTitle>Biomedical chromatography : BMC</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4d099021b017a4a40fe01dcb55d9ec0"><gtr:id>b4d099021b017a4a40fe01dcb55d9ec0</gtr:id><gtr:otherNames>Cai H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-3879</gtr:issn><gtr:outcomeId>pm_15429_19_18800334</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F2701D5-6B81-482B-9078-409622546A02</gtr:id><gtr:title>Rapid analysis of curcumin and curcumin metabolites in rat biomatrices using a novel ultraperformance liquid chromatography (UPLC) method.</gtr:title><gtr:parentPublicationTitle>Journal of agricultural and food chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee25f45cc85857bf9569d83c4b827c4f"><gtr:id>ee25f45cc85857bf9569d83c4b827c4f</gtr:id><gtr:otherNames>Marczylo TH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-8561</gtr:issn><gtr:outcomeId>6518C97E5EE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CB78AAA-5689-44F8-8671-4DE5AC8EE4DF</gtr:id><gtr:title>Putative cancer chemopreventive agents of dietary origin-how safe are they?</gtr:title><gtr:parentPublicationTitle>Nutrition and cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/626129829d68f8241cf9c6cb46c6565d"><gtr:id>626129829d68f8241cf9c6cb46c6565d</gtr:id><gtr:otherNames>Verschoyle RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0163-5581</gtr:issn><gtr:outcomeId>D912568EB13</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7C5DF42-C09F-4311-88B3-42C9049E6119</gtr:id><gtr:title>Androgen manipulation alters oxidative DNA adduct levels in androgen-sensitive prostate cancer cells grown in vitro and in vivo.</gtr:title><gtr:parentPublicationTitle>Cancer letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14183c5032f0f6dfbece3576956c8e8a"><gtr:id>14183c5032f0f6dfbece3576956c8e8a</gtr:id><gtr:otherNames>Pathak S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0304-3835</gtr:issn><gtr:outcomeId>1146AC88173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AE63EAD-4A7F-4034-9E44-28916C2DAE40</gtr:id><gtr:title>Phytoestrogens and xenoestrogens: the contribution of diet and environment to endocrine disruption.</gtr:title><gtr:parentPublicationTitle>The Journal of steroid biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0daadbdf101de142850213680aa78b58"><gtr:id>0daadbdf101de142850213680aa78b58</gtr:id><gtr:otherNames>Waring RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0960-0760</gtr:issn><gtr:outcomeId>EC234ED5F3A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F6B1C91-4423-4BB5-B53F-C55D7E0F8EA8</gtr:id><gtr:title>Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels.</gtr:title><gtr:parentPublicationTitle>European journal of cancer (Oxford, England : 1990)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/626129829d68f8241cf9c6cb46c6565d"><gtr:id>626129829d68f8241cf9c6cb46c6565d</gtr:id><gtr:otherNames>Verschoyle RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0959-8049</gtr:issn><gtr:outcomeId>144BFC3D5BF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>894E69F5-54DD-454D-81A7-2CD88D22FB9A</gtr:id><gtr:title>Consumption of silibinin, a flavonolignan from milk thistle, and mammary cancer development in the C3(1) SV40 T,t antigen transgenic multiple mammary adenocarcinoma (TAg) mouse.</gtr:title><gtr:parentPublicationTitle>Cancer chemotherapy and pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/626129829d68f8241cf9c6cb46c6565d"><gtr:id>626129829d68f8241cf9c6cb46c6565d</gtr:id><gtr:otherNames>Verschoyle RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0344-5704</gtr:issn><gtr:outcomeId>C5D3F8FC278</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D58EE685-06EC-4B64-B25E-89ACE8CE6757</gtr:id><gtr:title>APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the Apc(Min) mouse model in vivo.</gtr:title><gtr:parentPublicationTitle>European journal of cancer (Oxford, England : 1990)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79601c276cd9e784c40ff2c0b6413954"><gtr:id>79601c276cd9e784c40ff2c0b6413954</gtr:id><gtr:otherNames>Sale S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-8049</gtr:issn><gtr:outcomeId>pm_15429_19_19695862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>202FF660-49D7-4633-89F6-7E17E8BC7A9A</gtr:id><gtr:title>Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, apigenin and quercetin.</gtr:title><gtr:parentPublicationTitle>Cancer chemotherapy and pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49b8c0744562c6f7b7489f53d3ae9d0a"><gtr:id>49b8c0744562c6f7b7489f53d3ae9d0a</gtr:id><gtr:otherNames>Al-Fayez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0344-5704</gtr:issn><gtr:outcomeId>C05795B415F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD9D9739-ED49-4E65-8234-A697A8A14BF7</gtr:id><gtr:title>Tissue distribution in mice and metabolism in murine and human liver of apigenin and tricin, flavones with putative cancer chemopreventive properties.</gtr:title><gtr:parentPublicationTitle>Cancer chemotherapy and pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4d099021b017a4a40fe01dcb55d9ec0"><gtr:id>b4d099021b017a4a40fe01dcb55d9ec0</gtr:id><gtr:otherNames>Cai H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0344-5704</gtr:issn><gtr:outcomeId>6202A68A193</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58E82A04-2DCD-4065-B896-70D7E4C0E0DC</gtr:id><gtr:title>Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/626129829d68f8241cf9c6cb46c6565d"><gtr:id>626129829d68f8241cf9c6cb46c6565d</gtr:id><gtr:otherNames>Verschoyle RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>51184F04330</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17C5D86B-100E-4340-8041-A6F96AB02F58</gtr:id><gtr:title>Quantitation of silibinin, a putative cancer chemopreventive agent derived from milk thistle (Silybum marianum), in human plasma by high-performance liquid chromatography and identification of possible metabolites.</gtr:title><gtr:parentPublicationTitle>Journal of agricultural and food chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1f702d32b95174ca95956751a2173f2"><gtr:id>e1f702d32b95174ca95956751a2173f2</gtr:id><gtr:otherNames>Hoh CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-8561</gtr:issn><gtr:outcomeId>99DE1B4BA17</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CC1C514-948F-47D8-898E-9D55DF17E0F2</gtr:id><gtr:title>Pharmacokinetics and metabolism of the putative cancer chemopreventive agent cyanidin-3-glucoside in mice.</gtr:title><gtr:parentPublicationTitle>Cancer chemotherapy and pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee25f45cc85857bf9569d83c4b827c4f"><gtr:id>ee25f45cc85857bf9569d83c4b827c4f</gtr:id><gtr:otherNames>Marczylo TH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0344-5704</gtr:issn><gtr:outcomeId>pm_15429_19_19363608</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C333FD3A-3F4F-4065-864E-683225F1B183</gtr:id><gtr:title>Cytotoxic action of phorbol esters on human pancreatic cancer cells.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1e7e155c709c236cd3cef8c6040922b"><gtr:id>c1e7e155c709c236cd3cef8c6040922b</gtr:id><gtr:otherNames>Bond JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>A604C7C66C0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2368AD52-E3C1-44EE-AB76-470063565ED5</gtr:id><gtr:title>Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.</gtr:title><gtr:parentPublicationTitle>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89162a41d6a06821b22382717aa58da9"><gtr:id>89162a41d6a06821b22382717aa58da9</gtr:id><gtr:otherNames>Boocock DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1055-9965</gtr:issn><gtr:outcomeId>904CF8179BB</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0100874</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>4F7FE31F-D266-4FE9-9BAB-3D21E9B789BA</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>3.3  Nutrition and chemoprevention</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>